BABIO Launches High-Performance Adenovirus Antigen Detection Kit to Meet Global Diagnostic Demands
As global awareness of respiratory and gastrointestinal infections rises, rapid and accurate diagnostic tools have become essential for timely public health responses. BABIO, a leading in-vitro diagnostics manufacturer based in China, announces the international availability of its Adenovirus Antigen Detection Kit (Colloidal Gold Method)—a powerful lateral flow immunoassay designed for fast, reliable adenovirus screening.
Fast and Reliable Screening for Adenovirus Infection
Adenoviruses are common pathogens responsible for a range of infections including respiratory illnesses, conjunctivitis, and gastrointestinal disorders, particularly in children and immunocompromised individuals. BABIO’s latest Adenovirus Antigen Detection Kit is optimized for nasopharyngeal swabs, saliva, and fecal specimens, making it an ideal solution for hospitals, clinics, and field health services across Europe, Africa, Southeast Asia, and the Americas.
The test provides qualitative results within 10–15 minutes, offering early clinical insights to healthcare professionals. Its easy-to-use format and internal control line ensure high confidence and accuracy, even in decentralized or low-resource settings.
Features & Advantages
-
Rapid Results: Clear positive or negative readout in minutes
-
High Specificity: Detects adenovirus antigens with targeted monoclonal antibodies
-
User-Friendly Format: No specialized equipment required
-
Multipoint Application: Suitable for saliva, feces, or nasopharyngeal swab specimens
-
Stable Shelf Life: Up to 12 months at room temperature (2-30°C)
Commitment to Global Diagnostics
BABIO has earned recognition as a trusted name in the global diagnostics community. With robust manufacturing capabilities and international certifications, the company continues to innovate diagnostic solutions that respond to emerging health needs. The Adenovirus Antigen Detection Kit has been developed to support early diagnosis, outbreak control, and screening initiatives globally.
Healthcare providers, distributors, and procurement managers are encouraged to explore BABIO’s full range of infectious disease testing solutions. For specifications, demo requests, or partnership inquiries, please visit the official BABIO website: www.babiocorp.com
#AdenovirusTest #RapidDiagnostics #BABIO #ColloidalGold #InfectiousDiseases #GlobalHealth #DiagnosticKit #MedicalDevices